ORASURE TECHNOLOGIES INC
For the period ended Dec 31, 2023. Filed Mar 11, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 11, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on March 11, 2024.
| ORASURE TECHNOLOGIES, INC. | |
| By: | /s/ Carrie Eglinton Manner |
| Carrie Eglinton MannerPresident and Chief Executive Officer |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed on March 11, 2024, by the following persons on behalf of the Registrant and in the capacities indicated.
| SIGNATURE | TITLE |
|---|---|
| /s/ Carrie Eglinton Manner | President, Chief Executive Officer and Director (Principal Executive Officer) |
| Carrie Eglinton Manner | |
| /s/ Kenneth J. McGrath | Chief Financial Officer (Principal Financial Officer) |
| Kenneth J. McGrath | |
| /s/ Michele Anthony | Senior Vice President, Controller & Chief Accounting Officer(Principal Accounting Officer) |
| Michele Anthony | |
| *MARA G. ASPINALL | Director |
| Mara G. Aspinall | |
| *JAMES A. DATIN | Director |
| James A. Datin | |
| *NANCY J. GAGLIANO | Director |
| Nancy J. Gagliano | |
| *LELIO MARMORA | Director |
| Lelio Marmora | |
| *ROBERT W. MCMAHON | Director |
| Robert W. McMahon | |
| *DAVID J. SHULKIN, M.D. | Director |
| David J. Shulkin, M.D. | |
| *By: | /s/Stefano Taucer |
| Stefano Taucer | |
| (Attorney-in-Fact) | |
Index to Consolidated Financial Statements
| Page | |
| Report of Independent Registered Public Accounting Firm (KPMG LLP, Philadelphia, PA, Auditor Firm ID:185) | F-2 |
|---|---|
| Consolidated Balance Sheets | F-4 |
| Consolidated Statements of Operations | F-5 |
| Consolidated Statements of Comprehensive Income (Loss) | F-6 |
| Consolidated Statements of Stockholders’ Equity | F-7 |
| Consolidated Statements of Cash Flows | F-8 |
| Notes to the Consolidated Financial Statements | F-9 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.